Clinical Trials in San Antonio

Showing 5981-6000 of 14,633 trials

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors

NCT05698888

This study will test the safety, tolerability, and pharmacokinetics of VP301 in patients with relapsed or refractory multiple myeloma, lymphoma, or solid tumors.

Solid Tumors, AdultMultiple MyelomaLymphoma

Virtuoso BINco, Inc.2 participantsStarted Nov 2022

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

NCT02760433

The purpose of this study was to determine how effective and safe the study drug Olokizumab was in patients with Rheumatoid Arthritis (RA) who had been already receiving, but not fully responding to treatment with an existing medication called a tumour necrosis factor alpha inhibitor The primary objective of this study was to evaluate the efficacy of olokizumab (OKZ) 64 mg administered subcutaneously (SC) once every 2 weeks (q2w) or once every 4 weeks (q4w) relative to placebo in subjects with moderately to severely active rheumatoid arthritis (RA) inadequately controlled by TNF-α inhibitor (TNFi) therapy.

Rheumatoid Arthritis

R-Pharm International, LLC368 participantsStarted Jan 2017

Phoenix, Arizona, United States • Hot Springs, Arkansas, United States • Covina, California, United States +113 more locations

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

Find Trials by Condition in San Antonio

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Impact of Fever Prevention in Brain Injured Patients

A Study of BTX-1188 in Subjects With Advanced Malignancies

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Addressing Dementia Via Agitation-Centered Evaluation

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

Human Epilepsy Project 2: Resistant Focal Seizures Study

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Multi-Center Pilot Study of truSculpt Device